AGITG - Australasian Gastro Intestinal Trial Group

AGITG Trial News

The AGITG currently has six studies open to recruitment and eleven studies in follow up.

The  table below details the trials that are currently accruing patients.

Recruited

Target

ACTICCA-1- Gallbladder carcinoma 2 50
ASCOLT — Colorectal cancer 271 300
CONTROL NETs — NeuroEndocrine Tumour 66 72
INTEGRATE II –  Gastro-Oesophageal 23 350
NABNEC  — NeuroEndocrine Tumour 16 70
TOP GEAR — Stomach cancer 187 752

Recruitment figures to end January 2017.

Trial Results Lay Summaries (click on the links below):

ALaCaRT
ATTACHE
ATTAX-3
GAP
ICECREAM
INTEGRATE
TACTIC
TOP GEAR
CO.17
EORTC 62024
Advanced GIST